D-1343-2014 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-1343-2014 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 14, 2014 and is designated Class II. Reason for recall: Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle. Chemical analysis of the contaminant found on the cotton was identified as a formulation… The recall status is terminated (terminated Aug 13, 2015). Affected quantity: 14,496 bottles.

Recall details

Product Type
Drugs
Report Date
May 28, 2014
Initiation Date
Apr 14, 2014
Termination Date
Aug 13, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,496 bottles

Product description

phosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical Care North America, Waltham, MA 02451, NDC 0781-2081-02

Reason for recall

Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle. Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..

Distribution pattern

PA

Code information

Lot # 13064, 13065, 13066; Exp. 08/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1343-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1343-2014. Report a data issue: hello@regdatalab.com.